- Home
- LXEO vs RPT Comparison
LXEO vs RPT Comparison
Compare LXEO & RPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LXEO
- RPT
- Stock Information
- Founded
- LXEO 2017
- RPT 2014
- Country
- LXEO United States
- RPT United States
- Employees
- LXEO N/A
- RPT N/A
- Industry
- LXEO
- RPT
- Sector
- LXEO
- RPT
- Exchange
- LXEO Nasdaq
- RPT NYSE
- Market Cap
- LXEO 140.6M
- RPT 156.7M
- IPO Year
- LXEO 2023
- RPT N/A
- Fundamental
- Price
- LXEO $4.10
- RPT $2.85
- Analyst Decision
- LXEO Strong Buy
- RPT Strong Buy
- Analyst Count
- LXEO 5
- RPT 1
- Target Price
- LXEO $22.80
- RPT $4.00
- AVG Volume (30 Days)
- LXEO 919.4K
- RPT 238.3K
- Earning Date
- LXEO 03-24-2025
- RPT 01-01-0001
- Dividend Yield
- LXEO N/A
- RPT 8.32%
- EPS Growth
- LXEO N/A
- RPT N/A
- EPS
- LXEO N/A
- RPT N/A
- Revenue
- LXEO N/A
- RPT N/A
- Revenue This Year
- LXEO N/A
- RPT N/A
- Revenue Next Year
- LXEO N/A
- RPT N/A
- P/E Ratio
- LXEO N/A
- RPT N/A
- Revenue Growth
- LXEO N/A
- RPT N/A
- 52 Week Low
- LXEO $2.32
- RPT $2.65
- 52 Week High
- LXEO $19.50
- RPT $3.94
- Technical
- Relative Strength Index (RSI)
- LXEO 57.61
- RPT N/A
- Support Level
- LXEO $3.75
- RPT N/A
- Resistance Level
- LXEO $4.59
- RPT N/A
- Average True Range (ATR)
- LXEO 0.48
- RPT 0.00
- MACD
- LXEO 0.24
- RPT 0.00
- Stochastic Oscillator
- LXEO 76.89
- RPT 0.00
About LXEO Lexeo Therapeutics Inc.
Lexeo Therapeutics Inc is a a clinical-stage genetic medicines company dedicated to transforming healthcare by applying pioneering science to fundamentally change how disease is treated. Its pipeline consists of candidates targeting patient populations that place significant burden on society and are most amenable to their genetic medicine approach. The Company is focused on preclinical and clinical stage gene therapies, and specifically on hereditary and acquired diseases of high unmet need which is their only business segment.
About RPT RITHM PROPERTY TRUST INC
Rithm Property Trust Inc is a real estate investment trust (REIT) externally managed by an affiliate of Rithm Capital Corp. (Rithm). The group is embarking on a new commercial real estate-focused investment. Its tailored approach to investment management seeks to generate attractive risk-adjusted returns for stockholders over the long term through dividends and capital appreciation.